Wed, 23rd Jun 2021 20:22
Tissue Regenix Group PLC - regenerative medical devices company - Says Non-Executive Director Brian Phillips buy 3.4 million shares at a price of 0.6 pence each. The transaction, which was completed on Friday last week, was worth GBP20,617.
Current stock price: 0.64p
Year-to-date change: up 19%
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses.
Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish lo...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Tissue Regenix Group (TRX)